Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 236.90
+6.00 (2.60%)
At close: Apr 1, 2026
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of 1.05 trillion as of April 2, 2026. Its market cap has decreased by -55.31% in one year.
Market Cap
1.05T
Enterprise Value
1.16T
Revenue
309.06B
Ranking
n/a
PE Ratio
10.29
Stock Price
236.90
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 46.00B to 1.05T, an increase of 2,186.37%. That is a compound annual growth rate of 11.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 1.05T | -27.22% |
| Dec 30, 2025 | 1.45T | -47.87% |
| Dec 30, 2024 | 2.77T | -10.93% |
| Dec 29, 2023 | 3.11T | 46.89% |
| Dec 30, 2022 | 2.12T | 26.50% |
| Dec 30, 2021 | 1.67T | 69.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 103.29B |
| Coloplast | 96.84B |
| ALK-Abelló | 44.76B |
| Demant | 39.52B |
| H. Lundbeck | 37.57B |
| Zealand Pharma | 20.76B |
| Ambu A/S | 17.93B |
| Bavarian Nordic | 14.88B |